Adderall XR

DRUG2 trials

Sponsors

New River Pharmaceuticals, Sarah Morrow

Conditions

Attention Deficit Disorder With HyperactivityMultiple Sclerosis

Phase 2

NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD

CompletedNCT00557011

New River PharmaceuticalsAttention Deficit Disorder With Hyperactivity

Start: 2004-09-30End: 2004-12-31Updated: 2011-05-25

Adderall XR and Cognitive Impairment in MS

Active, not recruitingNCT02676739

Sarah MorrowMultiple Sclerosis

Start: 2016-05-20End: 2024-12-31Target: 180Updated: 2024-10-17

Related Papers

A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder.

2009-06-0994 citations